List of largest biomedical companies by revenue

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

The following is a list of the top independent pharmaceutical, biotechnology and medical companies ranked by their revenue generated in (billion dollars) in the respective financial year, it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.

The change is the companies relative position in this list, compared to their relative position in the prior year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the previous year, red cells indicate those years where there has been a decrease.

Top pharmaceutical companies with revenue over $10 billion[edit]

Rank Chg Company 2020
USD billions
2019
USD billions
2018
USD billions
2017
USD billions
2016
USD billions
2015
USD billions
2014
USD billions
2013
USD billions
2012
USD billions
2011
USD billions
1 Steady United States Johnson & Johnson
NYSEJNJ
82.58[1] 82.06[2] 81.60[3] 76.50[4] 71.89[5] 70.10[6] 74.30[7] 71.31[8] 67.20[9] 65.00[10]
2 Increase 1 China Sinopharm
SEHK1099
69.50[11] 60.18[12] 48.75[13] 43.63[14] 36.56[15] 32.36[16] 28.32[17] 23.61[18] 19.31[19] 14.46[20]
3 Decrease 1 Switzerland Roche
SIXROG
64.60[21] 63.85[22] 56.86[23] 57.37[24] 50.11[25] 47.70[26] 49.86[27] 48.53[28] 47.80[29] 45.21[30]
4 Increase 1 Germany Bayer
FWBBAYN
49.99[31] 48.02 [32] 45.06[33] 37.94[34] 25.27[35] 24.09[36] 25.47[37] 24.17[38] 24.30[39] 23.11[40]
5 Increase 1 Switzerland Novartis
NYSENVS
48.66[41] 47.45[42] 44.75[43] 49.11[44] 48.52[45] 49.41[46] 58.00[47] 57.36[48] 56.67[49] 58.57[50]
6 Increase 1 United States Merck & Co.
NYSEMRK
47.99[51] 46.84[52] 42.30[53] 40.10[54] 39.80[55] 39.50[56] 42.24[57] 44.03[58] 47.27[59] 48.05[60]
7 Increase 1 United Kingdom GlaxoSmithKline
LSEGSK
46.52[61] 43.92[62] 43.14[63] 42.05[64] 34.79[65] 29.84[66] 37.96[67] 41.61[68] 39.93[69] 41.39[70]
8 Increase 1 United States AbbVie
NYSEABBV
45.78[71] 33.27[72] 32.75[73] 28.22[74] 25.56[75] 22.82[76] 19.96[77] 18.79[78]
9 Increase 1 France Sanofi
NYSESNY
43.21[79] 39.28[80] 39.07[81] 42.91[82] 36.57[83] 36.73[84] 43.07[85] 42.08[86] 46.41[87] 44.34[88]
10 Increase 5 United States Bristol Myers Squibb
NasdaqBMY
42.52[89] 26.15[90] 22.56[91] 20.80[92] 19.43[93] 16.56[94] 15.88[95] 16.39[96] 17.62[97] 21.24[98]
11 Decrease 7 United States Pfizer
NYSEPFE
41.91[99] 51.75[100] 53.60[101] 52.54[102] 52.82[103] 48.85[104] 49.61[105] 51.58[106] 58.99[107] 65.26[108]
12 Decrease 1 United States Abbott Laboratories
NasdaqABT
34.61[109] 31.90[110] 30.60[111] 27.39[112] 20.85[113] 20.41[114] 20.25[115] 21.85[116] 39.87[117] 38.85[118]
13 Steady United States Thermo Fisher Scientific
NYSETMO
32.22[119] 25.54[120] 24.36[120] 20.92[121] 18.27[122] 16.97[123] 16.89[124] 13.09[124] 12.51[125] 11.56[125]
14 Decrease 2 United States Medtronic
NYSEMDT
28.91[126] 30.56[127] 29.95[128] 29.71[129] 20.94[130] 20.26[131] 17.01[132] 16.59[133] 16.18[134] 15.93[135]
15 Steady Japan Takeda Pharmaceutical
TYO: 4502
23.02 Q3[136] 31.17[137] 19.10[138] 16.70[139] 15.96[140] 14.93 16.84 17.36 18.91 17.80
16 Steady United Kingdom/Sweden AstraZeneca
LSEAZN
26.62[141] 24.38[142] 22.09[143] 22.47[144] 23.00[145] 24.71[146] 26.10[147] 25.71[148] 27.97[149] 33.59[150]
17 Steady United States Amgen
NasdaqAMGN
25.42[151] 23.40[152] 23.70[153] 22.80[154] 22.99[155] 21.66[156] 20.06[157] 18.68[158] 17.30[159] 15.58[160]
18 Steady United States Gilead Sciences
NasdaqGILD
24.69[161] 22.45[162] 22.13[163] 25.70[164] 30.39[164] 32.15[164] 24.47[164] 10.80[164] 9.70[164] 8.39[164]
19 Steady United States Eli Lilly & Co
NYSELLY
24.54[165] 22.32[166] 21.49[167] 22.90[168] 21.22[169] 20.00[170] 19.62[171] 23.11[172] 22.60[173] 24.29[174]
20 Increase 1 Germany Boehringer Ingelheim
Private
22.98[175] 19.48[176] 21.67[177] 17.54[178] 16.41[178] 17.70[178] 18.68[178] 18.89[178] 18.34[178]
21 Increase 3 United States Danaher Corporation
NYSEDHR
22.28[179] 17.91[180] 19.89[181] 18.33[182] 16.88[183] 20.56[184] 19.91[185] 19.12[186] 18.26[187] 16.09[188]
22 Increase 1 Germany Merck Group
ETR: MRK
21.09[189] 18.25[190] 16.48[191] 18.70[192] 16.62[193] 14.25[194] 15.29[195] 14.73[192] 14.36[192] 14.31[192]
23 Decrease 1 Denmark Novo Nordisk
NYSENVO
20.53[196] 18.30[197] 16.99[198] 18.77[199] 16.61[200] 16.06[201] 15.83[202] 14.88[203] 13.48[204] 11.56[205]
24 Steady United States Viatris
NasdaqVTRS
18.15[206]
25 Decrease 4 United States GE Healthcare
Subsidiary of General Electric
18.01[207] 19.94[208] 19.78[209] 19.02[210] 18.21[211] 17.64[212] 18.30[213] 18.20[214] 18.29[215]
26 Increase 1 Germany Siemens Healthineers
FWBSHL
17.50[216] 16.29[217] 15.44[218] 16.56[219] 14.25[220] 14.06[221]
27 Increase 4 United States Medline Industries
Private
17.5[222] 13.9[223] 11.7[224]
28 Decrease 2 United States Becton, Dickinson and Company
NYSEBDX
17.12[225] 17.29[226] 15.98[227] 12.09[228] 12.48[229] 10.28[230] 8.45[231] 8.05[232] 7.71[233] 7.58[234]
29 Decrease 2 Israel/United States Teva Pharmaceutical Industries
NasdaqTEVA
16.66[235] 16.89[236] 18.90[237] 22.40[238] 21.90[239] 20.00[240] 20.27[241] 20.31[242] 18.31[243] 16.12[244]
30 Decrease 1 United States Stryker Corporation
NYSESYK
14.35[245] 14.88[246] 13.60[247] 12.44[247] 11.33[248] 9.95[248] 9.68[249] 9.02[249] 8.66[250] 8.31[250]
31 Increase 2 United States Labcorp
NYSELH
13.98[251] 11.55[252] 11.33[253] 10.31[253] 9.55[253] 8.51[253] 6.01[253] 5.81[254] 5.67[254] 5.54[254]
32 Decrease 2 United States Biogen
NasdaqBIIB
13.44[255] 14.38[256] 13.45[257] 12.30[258] 11.40[259] 10.80[260] 9.70[261] 6.90[262] 5.50[263] 5.00[264]
33 Decrease 1 Japan Astellas Pharma
TYO: 4503
8.64 Q3[265] 12.20[266] 12.27[267] 12.07 12.63 11.48 10.49 9.25 8.92 8.78
34 Steady United States Baxter International
NYSEBAX
11.67[268] 11.36[269] 11.13 [270] 10.56 [270] 10.16 [271] 9.97 [272] 10.72 [273] 14.97 [274] 14.19 [275] 13.89 [275]
35 Steady United States IQVIA
NYSEIQV
11.36[276] 11.09 [277] 10.41 [278] 9.70 [279] 5.36 [280] 4.33 [281] 4.17 [282] 3.81 [283] 3.69 [284]

See also[edit]

Notes[edit]

References[edit]

  1. ^ https://johnsonandjohnson.gcs-web.com/static-files/b23c74b5-3cd3-4c2e-8c67-035aa484749f
  2. ^ "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results: | BioSpace".
  3. ^ "Johnson & Johnson Reports 2018 Fourth-Quarter Results:". Content Lab - U.S.
  4. ^ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  5. ^ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  6. ^ "Johnson & Johnson Reports 2015 Fourth-Quarter Results:". Archived from the original on 2016-02-11. Retrieved 2018-01-28.
  7. ^ "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  8. ^ "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  9. ^ "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results:".
  10. ^ "Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:".
  11. ^ http://ir.sinopharmgroup.com.cn/attachment/202103220719031745656453_en.pdf
  12. ^ http://ir.sinopharmgroup.com.cn/attachment/202004240816014279248723_en.pdf
  13. ^ http://ir.sinopharmgroup.com.cn/attachment/2019042506350100033473013_en.pdf
  14. ^ http://ir.sinopharmgroup.com.cn/attachment/2018042506320200033121116_en.pdf
  15. ^ http://ir.sinopharmgroup.com.cn/attachment/2017042106200200012785604_en.pdf
  16. ^ http://ir.sinopharmgroup.com.cn/attachment/201607131609541765679138_en.PDF
  17. ^ http://ir.sinopharmgroup.com.cn/attachment/2015041006320100032166702_en.pdf
  18. ^ http://ir.sinopharmgroup.com.cn/attachment/20140410061701001886801_en.pdf
  19. ^ http://ir.sinopharmgroup.com.cn/attachment/20130419164701001633683_en.pdf
  20. ^ http://ir.sinopharmgroup.com.cn/attachment/20120420064701001411060_en.pdf
  21. ^ https://www.roche.com/dam/jcr:3bc1f151-1def-483b-868c-8bd1ef59ccc4/en/irp210204-a.pdf
  22. ^ https://www.roche.com/dam/jcr:e49f6995-e813-43c1-9302-c9b7d0bddbc8/en/irp200130-a.pdf
  23. ^ https://www.roche.com/dam/jcr:af865dfd-50fb-458b-9cac-34097db9d3ec/en/ar18e.pdf
  24. ^ "Roche reports good results in 2017". www.roche.com.
  25. ^ https://www.roche.com/dam/jcr:ee2f197f-5487-4629-9e28-66b77c9cbbab/en/ar16e.pdf
  26. ^ https://www.roche.com/dam/jcr:9b36e11d-495c-42f5-b757-e80c4e88d793/en/gb15e.pdf
  27. ^ https://www.roche.com/dam/jcr:880b44a1-3fd6-4e66-bf10-f4af1e724d4d/en/gb14e.pdf
  28. ^ https://www.roche.com/dam/jcr:64fd6b2d-1a76-467f-badd-ab94b85b6d70/en/gb13e.pdf
  29. ^ https://www.roche.com/dam/jcr:3e048249-e3ce-4969-a77e-cc90d8f3fa73/en/gb12e.pdf
  30. ^ https://www.roche.com/dam/jcr:52174b39-feab-4210-82f6-9b8786a69ecf/en/gb11e.pdf
  31. ^ https://www.bayer.com/sites/default/files/2021-02/Bayer-Annual-Report-2020.pdf
  32. ^ "Bayer AG Annual Report 2019" (PDF). www.bayer.com.
  33. ^ "Bayer's Annual Report 2018". www.annualreport2018.bayer.com.
  34. ^ http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf
  35. ^ http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf
  36. ^ http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf
  37. ^ AG, Bayer. "Bayer – Global Home". www.bayer.com.
  38. ^ https://www.bayer.com/en/ar-2013.pdfx
  39. ^ https://www.bayer.com/en/ar-2012.pdfx
  40. ^ https://www.bayer.com/en/ar-2011.pdfx
  41. ^ https://www.novartis.com/sites/www.novartis.com/files/2021-01-interim-financial-report-en.pdf
  42. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2019-media-release-en.pdf
  43. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf
  44. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.CS1 maint: archived copy as title (link)
  45. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf
  46. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf
  47. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf
  48. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf
  49. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf
  50. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2011-en.pdf
  51. ^ https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2020-financial-results/
  52. ^ https://www.biospace.com/article/releases/merck-announces-fourth-quarter-and-full-year-2019-financial-results/?s=72
  53. ^ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  54. ^ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket".
  55. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf
  56. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf
  57. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf
  58. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf
  59. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf
  60. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2011/annual/form-10-k-2011.pdf
  61. ^ https://www.gsk.com/media/6557/fy-2020-results-announcement.pdf
  62. ^ https://www.gsk.com/media/5820/fy-2019-results-announcement.pdf
  63. ^ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
  64. ^ https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf
  65. ^ https://www.gsk.com/media/3609/annual-report-2016.pdf
  66. ^ https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf
  67. ^ https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf
  68. ^ https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf
  69. ^ https://www.gsk.com/media/2694/annual-report-2012.pdf
  70. ^ https://www.gsk.com/media/2696/annual-report-2011.pdf
  71. ^ https://investors.abbvie.com/static-files/28ec0c10-474f-4b35-9133-1518835fd31e
  72. ^ https://www.biospace.com/article/releases/abbvie-reports-full-year-and-fourth-quarter-2019-financial-results/?s=72
  73. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  74. ^ "Financial Release - AbbVie". investors.abbvie.com.
  75. ^ "Financial Release - AbbVie". investors.abbvie.com.
  76. ^ "Financial Release - AbbVie". investors.abbvie.com.
  77. ^ "Financial Release - AbbVie". investors.abbvie.com.
  78. ^ "Financial Release - AbbVie". investors.abbvie.com.
  79. ^ https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q4-results-2020
  80. ^ https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q4-results-2019
  81. ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560
  82. ^ https://www.sanofi.com/media/Project/One-Sanofi-Web/sanofi-com/en/investors/docs/press-releases/Press_release_Q4_FY_2017.pdf
  83. ^ https://en.sanofi.com/Images/49288_20-F_2016.pdf
  84. ^ https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf
  85. ^ https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf
  86. ^ https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf
  87. ^ https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf
  88. ^ https://en.sanofi.com/Images/29804_20F_2011.pdf
  89. ^ https://s21.q4cdn.com/104148044/files/doc_financials/quarterly_reports/2020/BMY-Q42020-Earnings-Press-Release.pdf
  90. ^ https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79
  91. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  92. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  93. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  94. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  95. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
  96. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
  97. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf
  98. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/BristolMyersSquibb-2011-AnnualReport.pdf
  99. ^ https://s21.q4cdn.com/317678438/files/doc_financials/2020/q4/Q4-2020-PFE-Earnings-Release.pdf
  100. ^ "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS | BioSpace".
  101. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2018/q4/Q4-2018-PFE-Earnings-Release.pdf
  102. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf
  103. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf
  104. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf
  105. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf
  106. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf
  107. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf
  108. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2011/financial2011.pdf
  109. ^ https://www.abbottinvestor.com/static-files/b225dfc0-1f17-4ff9-b8c7-c995bf7ea03e
  110. ^ https://www.biospace.com/article/releases/abbott-reports-fourth-quarter-2019-results-announces-strong-forecast-for-2020/?s=72
  111. ^ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  112. ^ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  113. ^ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  114. ^ "Abbott Reports Fourth-Quarter 2015 Results".
  115. ^ "Abbott Reports Fourth-Quarter 2014 Results".
  116. ^ Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
  117. ^ "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
  118. ^ "Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings - FiercePharma". www.fiercepharma.com.
  119. ^ http://d18rn0p25nwr6d.cloudfront.net/CIK-0000097745/e8ed1418-dec6-4147-b378-48498ca8a954.pdf
  120. ^ a b https://www.biospace.com/article/releases/thermo-fisher-scientific-reports-fourth-quarter-and-full-year-2019-results/?s=72
  121. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2018/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2017-Results/default.aspx
  122. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2017/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2016-Results/default.aspx
  123. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2016/Thermo-Fisher-Scientific-Reports-Record-Fourth-Quarter-and-Full-Year-2015-Results/default.aspx
  124. ^ a b https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2015/Thermo-Fisher-Scientific-Reports-Strong-Fourth-Quarter-and-Full-Year-2014-Results/default.aspx
  125. ^ a b http://thermofisher.mediaroom.com/2013-01-31-Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2012-Results
  126. ^ https://investorrelations.medtronic.com/static-files/9a576213-cdd1-41e9-aa72-e2cbf15c1a8d
  127. ^ https://investorrelations.medtronic.com/static-files/da4767cb-a6c9-4716-801e-48a0a3155e1f
  128. ^ https://investorrelations.medtronic.com/static-files/262eb1cb-ed16-422c-b33c-d9f031105481
  129. ^ https://investorrelations.medtronic.com/static-files/b6508122-6f3b-473e-9638-8c8b8dc226a5
  130. ^ https://investorrelations.medtronic.com/static-files/5f89558e-dd8c-48ff-9645-a279cdd38460
  131. ^ https://investorrelations.medtronic.com/static-files/07b454a5-4517-402f-999e-e1db87ff991e
  132. ^ https://investorrelations.medtronic.com/static-files/bcc415af-20c5-4f19-9efa-9312bb36cf03
  133. ^ https://investorrelations.medtronic.com/static-files/91cd662f-ceb7-4442-8de5-43fbd51202f8
  134. ^ https://investorrelations.medtronic.com/static-files/35f7dd75-6583-4c3c-a731-b95fefbd9793
  135. ^ https://investorrelations.medtronic.com/static-files/7f6de2e5-cec2-47a2-b37e-980c66c7c478
  136. ^ https://www.takeda.com/48fe83/siteassets/system/investors/quarterly-announcements/fy2020/qr2020_q3_qfr_en.pdf
  137. ^ https://www.takeda.com/newsroom/newsreleases/2020/takeda-accelerates-transformation-solid-fy2019-results-confidence-in-fy2020-growth-momentum/
  138. ^ https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-fy2018-full-year-results-and-issues-fy2019-guidance/
  139. ^ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  140. ^ "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report" (PDF).
  141. ^ https://www.astrazeneca.com/content/dam/az/PDF/2020/full-year/Full-year_2020_results_announcement.pdf
  142. ^ https://www.astrazeneca.com/content/dam/az/PDF/2019/full-year/Full-year_and_Q4_2019_results_announcement.pdf
  143. ^ https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf
  144. ^ https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf
  145. ^ https://www.astrazeneca.com/content/dam/az/PDF/Full_year_and_q4_2016_results/Full_Year_and_Q4_2016_Results_announcement.pdf
  146. ^ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  147. ^ "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
  148. ^ "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
  149. ^ "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
  150. ^ "AstraZeneca PLC Fourth quarter and full year results 2011". www.astrazeneca.com.
  151. ^ https://investors.amgen.com/static-files/5c48bb65-ef7d-49d4-ad9f-aa8a683ba9e4
  152. ^ https://www.biospace.com/article/releases/amgen-reports-fourth-quarter-and-full-year-2019-financial-results/?s=72
  153. ^ "Amgen - Investors - Press Release". investors.amgen.com.
  154. ^ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  155. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1
  156. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1
  157. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1
  158. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1
  159. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1
  160. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTM0MzEzfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  161. ^ http://investors.gilead.com/static-files/7227feec-53b9-4809-8181-fa1441f34f31
  162. ^ https://www.biospace.com/article/releases/gilead-sciences-announces-fourth-quarter-and-full-year-2019-financial-results/?s=72
  163. ^ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  164. ^ a b c d e f g "Investor Overview". Gilead Sciences.
  165. ^ https://investor.lilly.com/static-files/ff47dd65-36a8-4bec-9c5a-62c4e494c8e1
  166. ^ https://www.biospace.com/article/releases/lilly-reports-strong-fourth-quarter-and-full-year-2019-financial-results-updates-2020-guidance-for-pending-dermira-acquisition/?s=72
  167. ^ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  168. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x970018/15B962F7-AF5A-4FFA-BE13-42206D3A0820/Q4_2017_PressRelease.pdf
  169. ^ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  170. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x871993/5BE670A3-2B82-4876-8471-CA6BC3BD49F8/Lilly_Q4_2015_Press_Release.pdf
  171. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x806120/8637C572-31C4-402E-A179-5E107A5366B2/Q414_Lilly_Sales_and_Earnings_Press_Release.pdf
  172. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x721860/2DB60538-94FE-4E96-98D2-DA72CC301EA0/Q413%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  173. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x631117/85679233-E13C-4FE7-9431-E97EFFDA6D5D/Q412%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  174. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x538046/24A15621-7850-45EC-8E20-30535C3D9FC9/Q411_Lilly_Sales_and_Earnings_Press_Release.pdf
  175. ^ https://www.boehringer-ingelheim.com/sites/default/files/ARPC/AR_2020/Boehringer-Ingelheim_Annual_Report_2020.pdf
  176. ^ http://annualreport.boehringer-ingelheim.com/fileadmin/Download-Center/BI_GB_18_en_ohne_Unterschriften.pdf
  177. ^ "Boehringer Ingelheim 2017 Annual Report" (PDF). www.boehringer-ingelheim.com.
  178. ^ a b c d e f "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
  179. ^ http://investors.danaher.com/image/4Q+2020+Danaher+Earnings+Presentation.pdf
  180. ^ http://investors.danaher.com/image/4Q2019+Danaher+Earnings+Presentation.pdf
  181. ^ http://investors.danaher.com/download/Danaher_Annual_Report_2018.pdf
  182. ^ http://investors.danaher.com/download/danaher_2017_annualreport.pdf
  183. ^ http://investors.danaher.com/download/Danaher_2016+Annual+Report.pdf
  184. ^ http://investors.danaher.com/download/2015+Danaher+Annual+Report.pdf
  185. ^ http://investors.danaher.com/download/DHR_AR_2014.pdf
  186. ^ http://investors.danaher.com/download/DHR_AR_2013.pdf
  187. ^ http://investors.danaher.com/download/DHR_AR_2012.pdf
  188. ^ http://investors.danaher.com/download/DHR_AR_2011.pdf
  189. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2020-q4/en/2020-Q4-Report-EN.pdf
  190. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2019-q4/en/2019-Q4-Report-EN.pdf
  191. ^ "Q4/FY Results of 2018 - News - Merck KGaA, Darmstadt, Germany". www.emdgroup.com.
  192. ^ a b c d "404 page - EMD Group". www.emdgroup.com.
  193. ^ http://ar2016.merckgroup.com/sites/default/files/downloads/en/merck_annual_report_2016.pdf
  194. ^ http://ar2015.emdgroup.com/sites/default/files/downloads/emd/Merck_GB2015_EN.pdf
  195. ^ http://ar2014.merckgroup.com/sites/default/files/downloads/en/Merck_GB2014_EN.pdf
  196. ^ https://www.novonordisk.com/content/dam/nncorp/global/en/investors/irmaterial/annual_report/2021/Novo-Nordisk-Annual-Report-2020.pdf
  197. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2020/20200502_Financial%20statement%20Q4%202019_UK.pdf
  198. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2019/20190201_Financial%20statement%20Q4%202018_UK.pdf
  199. ^ "News details". www.novonordisk.com.
  200. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2017/20170202_Financial%20statement_FY%202016_UK.pdf
  201. ^ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  202. ^ Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
  203. ^ Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
  204. ^ Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
  205. ^ http://www.novonordisk.co.uk/content/dam/Denmark/HQ/Commons/documents/Novo-Nordisk-AR-2011-en.pdf
  206. ^ https://investor.viatris.com/static-files/cdedc51f-115c-4a34-8134-9e7182dda6a9
  207. ^ https://www.ge.com/sites/default/files/ge_webcast_presentation_01262021.pdf
  208. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  209. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  210. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  211. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  212. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  213. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  214. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  215. ^ https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/
  216. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/180f4f3673c1bef8/747507c6608d/Siemens_Healthineers-_Annual-_Report_2020.pdf
  217. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000006835562/12e08501046c/Siemens-Healthineers-Annual-Report-2019.pdf
  218. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000005904947/ef806566e5ee/Annual-Report-2018.pdf
  219. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
  220. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
  221. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
  222. ^ https://www.medline.com/pages/about-us/stats-claims/
  223. ^ https://www.medline.com/pages/corporate-social-responsibility-2019-report/
  224. ^ https://www.medline.com/media/catalog/Docs/MKT/WP/CSR-2019.pdf
  225. ^ https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443
  226. ^ https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443
  227. ^ https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443
  228. ^ https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443
  229. ^ https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443
  230. ^ https://investors.bd.com/static-files/8cc141b1-2f6d-4cd4-8d24-faabe1f14b1e
  231. ^ https://investors.bd.com/static-files/8cc141b1-2f6d-4cd4-8d24-faabe1f14b1e
  232. ^ https://investors.bd.com/static-files/8cc141b1-2f6d-4cd4-8d24-faabe1f14b1e
  233. ^ https://investors.bd.com/static-files/8cc141b1-2f6d-4cd4-8d24-faabe1f14b1e
  234. ^ https://investors.bd.com/static-files/03dfef9f-a6e6-4d98-9b7f-39b5cee53055
  235. ^ https://s24.q4cdn.com/720828402/files/doc_financials/2020/q4/Teva_Q4-2020_Earnings-Presentation_Final.pdf
  236. ^ https://www.biospace.com/article/releases/teva-reports-fourth-quarter-and-full-year-2019-financial-results/?s=72
  237. ^ https://s24.q4cdn.com/720828402/files/doc_downloads/doc_financial/2018/q4/Teva-Form-10-K-2018.pdf
  238. ^ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results".
  239. ^ http://www.tevapharm.com/news/teva_reports_full_year_and_fourth_quarter_2016_financial_results_02_17.aspx
  240. ^ http://www.tevapharm.com/news/teva_reports_full_year_2015_and_fourth_quarter_financial_results_02_16.aspx
  241. ^ "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
  242. ^ http://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2013_results_02_14.aspx
  243. ^ "Teva Reports Fourth Quarter and Full Year 2012 Results". tevapharm.com.
  244. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTI2NDkwfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  245. ^ https://d18rn0p25nwr6d.cloudfront.net/CIK-0000310764/2051b683-79d9-40f5-8885-ec9e1e218a3f.pdf
  246. ^ https://investors.stryker.com/press-releases/news-details/2020/Stryker-reports-2019-results-and-2020-outlook/default.aspx
  247. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2018/Stryker_Annual_Report_2018.pdf
  248. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2016/STRYKER-2016-AR.pdf
  249. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2014/SYK_AR-14_4_29_15-FINAL.pdf
  250. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2012/SYK-2012-AR_-03-14-13-FINAL_Single-Pages.pdf
  251. ^ https://ir.labcorp.com/static-files/f377837c-0676-45e4-8678-932ab01f8814
  252. ^ https://ir.labcorp.com/static-files/753d1464-9421-43f1-be83-d5e0be586800
  253. ^ a b c d e http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDE2OTE0fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636873221632383468
  254. ^ a b c http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjI4ODI1fENoaWxkSUQ9LTF8VHlwZT0z&t=1
  255. ^ https://investors.biogen.com/static-files/e8fb597e-5179-4279-8ba1-48df48152d86
  256. ^ https://investors.biogen.com/static-files/ce31eed8-8862-4bec-a63f-77c0fd6e15a1
  257. ^ http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e
  258. ^ "Biogen's Spinraza: Great Launch, Rough Ride". 25 January 2018 – via www.bloomberg.com.
  259. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2016_on_Form_10K.pdf
  260. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2015_on_Form_10K.pdf
  261. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_2014_Annual_Report_Web.pdf
  262. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2013.pdf
  263. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2012.pdf
  264. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/2011ar.pdf
  265. ^ https://www.astellas.com/en/investors/financial-data-quarterly-data01
  266. ^ https://sw4503.swcms.net/en/ir-library/business-results/inframe/main/010/teaserItems1/00/linkList/0/link/4q2019_en_v1.pdf
  267. ^ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.
  268. ^ http://d18rn0p25nwr6d.cloudfront.net/CIK-0000010456/daa62a96-7bd6-47c4-97ed-b990d270227a.pdf
  269. ^ http://d18rn0p25nwr6d.cloudfront.net/CIK-0000010456/c8c941c6-2b54-474e-9ffd-e4be95a75a58.pdf
  270. ^ a b https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2018/q4/Q4-2018-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
  271. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2017/q4/Q4-2017-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
  272. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2016/q4/Q4-2016-Financial-Schedules.pdf
  273. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2015/q4/Q4-2015-Financial-Schedules.pdf
  274. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2014/q4/Q4-2014-FINAL-Financial-Schedules.pdf
  275. ^ a b https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2012/Reclassified-Sales-Final.pdf
  276. ^ https://s24.q4cdn.com/326377938/files/doc_financials/2020/q4/IQVIA-Q4-2020-Earnings-Press-Release-_-vFINAL.pdf
  277. ^ https://s24.q4cdn.com/326377938/files/doc_financials/2019/annual/IQV-2019-10-K-Filed-(with-exhibits).pdf
  278. ^ https://s24.q4cdn.com/326377938/files/doc_financials/2019/annual/IQV-2019-10-K-Filed-(with-exhibits).pdf
  279. ^ https://s24.q4cdn.com/326377938/files/doc_financials/2019/annual/IQV-2019-10-K-Filed-(with-exhibits).pdf
  280. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf
  281. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf
  282. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf
  283. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf
  284. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf

External links[edit]